Pricey Hepatitis C Drugs Denied to Almost Half of Medicaid Patients: Study

TUESDAY, Nov. 24, 2015 — Nearly half of Medicaid patients with chronic hepatitis C have been denied cutting-edge medications that would most likely cure their condition, due to tight controls that states have placed on coverage of the pricey drugs,…
Source: Topamax